Advancing Clinical Trials in Nursing Homes: A Proposed Roadmap to Success.
Advancing Clinical Trials in Nursing Homes: A Proposed Roadmap to Success.
复制标题
DOI:
10.1016/j.jamda.2021.11.034
复制
发表时间:
2022-03
影响因子:
7.6
通讯作者:
Zimmerman S
中科院分区:
文献类型:
--
作者:
Gurwitz JH;Quinn CC;Abi-Elias IH;Adams AS;Bartel R;Bonner A;Boxer R;Delude C;Gifford D;Hanson B;Ito K;Jain P;Magaziner JS;Mazor KM;Mitchell SL;Mody L;Nace D;Ouslander J;Reifsnyder J;Resnick B;Zimmerman S
An effective clinical research effort in nursing homes to address prevention and treatment of COVID-19 faced overwhelming challenges. Under the Health Care Systems Research Network-Older Americans Independence Centers AGING Initiative, a multidisciplinary Stakeholder Advisory Panel was convened to develop recommendations to improve the capability of the clinical research enterprise in US nursing homes. The Panel considered the nursing home as a setting for clinical trials, reviewed the current state of clinical trials in nursing homes, and ultimately developed recommendations for the establishment of a nursing home clinical trials research network that would be centrally supported and administered. This report summarizes the Panel’s recommendations, which were developed in alignment with the following core principles: build on available research infrastructure where appropriate; leverage existing productive partnerships of researchers with groups of nursing homes and nursing home corporations; encompass both efficacy and effectiveness clinical trials; be responsive to a broad range of stakeholders including nursing home residents and their care partners; be relevant to an expansive range of clinical and health care delivery research questions; be able to pivot as necessary to changing research priorities and circumstances; create a pathway for industry-sponsored research as appropriate; invest in strategies to increase diversity in study populations and the research workforce; and foster the development of the next generation of nursing home researchers.
登录
查看更多内容
影响因子:
6.3
作者:
Verdoorn BP;Evans TK;Hanson GJ;Zhu Y;Langhi Prata LGP;Pignolo RJ;Atkinson EJ;Wissler-Gerdes EO;Kuchel GA;Mannick JB;Kritchevsky SB;Khosla S;Rizza SA;Walston JD;Musi N;Lipsitz LA;Kiel DP;Yung R;LeBrasseur NK;Singh RJ;McCarthy T;Puskarich MA;Niedernhofer LJ;Robbins PD;Sorenson M;Tchkonia T;Kirkland JL
通讯作者:
Kirkland JL
DOI:
10.1001/jama.2021.88282021
发表时间:
2021-06-03
影响因子:
120.7
作者:
Cohen, Myron S.;Nirula, Ajay;Skovronsky, Daniel M.
通讯作者:
Skovronsky, Daniel M.
影响因子:
6.3
作者:
Tisminetzky M;Bayliss EA;Magaziner JS;Allore HG;Anzuoni K;Boyd CM;Gill TM;Go AS;Greenspan SL;Hanson LR;Hornbrook MC;Kitzman DW;Larson EB;Naylor MD;Shirley BE;Tai-Seale M;Teri L;Tinetti ME;Whitson HE;Gurwitz JH
通讯作者:
Gurwitz JH
影响因子:
6.3
作者:
Sierra, Felipe;Caspi, Avshalom;Fortinsky, Richard H.;Haynes, Laura;Lithgow, Gordon J.;Moffitt, Terrie E.;Olshansky, S. Jay;Perry, Daniel;Verdin, Eric;Kuchel, George A.
通讯作者:
Kuchel, George A.
DOI:
10.1111/j.1532-5415.1993.tb02055.x
发表时间:
1993-02-01
影响因子:
6.3
作者:
OUSLANDER, JG;SCHNELLE, JF
通讯作者:
SCHNELLE, JF